In Generics Game, Truemeds Pops A Margin Pill, Cracks The Pricing Code

Generics distribution and telemedicine startup Truemeds aims to bridge the accessibility gap in a market known for low-cost generics, but ruled by expensive branded drugs

By cutting out marketing and medical representative costs, it keeps 50-60% margin before discounting, and 20-30% after discounts, while still offering medicines at a lower price

The startup banks on medicines for chronic illnesses and plans to foray into the diagnostic space to expand the business

India, a $66.66 Bn-strong pharma giant, is in the…